Evidence map›Paper›PMID 32418954›Full record

ArticleInternal medicine (Tokyo, Japan)2020

Fulminant Tracheobronchial Aspergillosis in an Apparently Healthy Adult.

Hayato Moribuchi, Rumi Sato, Shuntaro Matsushima, Masaki Tominaga, Jun Sasaki, Masayuki Nakamura, Yuki Sakazaki, Mamoru Nishiyama, Tomoaki Hoshino, Tomotaka Kawayama

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hayato MoribuchiDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Rumi SatoDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Shuntaro MatsushimaKurume Medical Resident Center, Kurume University Hospital, Japan.
Masaki TominagaDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Jun SasakiDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Masayuki NakamuraDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Yuki SakazakiDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Mamoru NishiyamaDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Tomoaki HoshinoDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Tomotaka KawayamaDivision of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan.
Kurume University · JPKurume University Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 56-year-old healthy man who was a current smoker died from fulminant tracheobronchial aspergillosis despite a month of treatment with a combination of intravenous anti-fungal agents that had been started immediately after the diagnosis. This case report is important for understanding and managing fulminant Aspergillus infections in healthy subjects, although the pathogenesis and underlying pathways are still unknown.

Indexed as

Antifungal AgentsAspergillosisBronchitisFatal OutcomeHumansMaleMiddle AgedTracheitisAntifungal Agentsfulminanthealthy individualtracheobronchial aspergillosis

Identifiers

PMID32418954
PMCPMC7303448
OpenAlexW3025630215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.